Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy

SIMPLE SUMMARY: For many years, patients with breast cancer and brain metastases were excluded from participation in clinical trials. It was believed that anticancer drugs could not cross the blood–brain barrier. However, recent evidence strongly suggests that some drugs can act against brain metast...

Descripción completa

Detalles Bibliográficos
Autores principales: Niwinska, Anna, Pogoda, Katarzyna, Jagiello-Gruszfeld, Agnieszka, Duchnowska, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869862/
https://www.ncbi.nlm.nih.gov/pubmed/35205723
http://dx.doi.org/10.3390/cancers14040965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869862/
https://www.ncbi.nlm.nih.gov/pubmed/35205723
http://dx.doi.org/10.3390/cancers14040965

Ejemplares similares